Myelo Therapeutics

Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis.Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.